Skip to content

The moderating and mediating effects of mindful compassion with body-mind-spirit therapy using a blended approach of face-to-face with online for breast cancer patients' depression during COVID-19: A randomized controlled trial.

Fei-Hsiu Hsiao, Chiao Lo, Wen-Hung Kuo, Chia-Chen Hsieh, Chiun-Sheng Huang

Internet Interventions April 21, 2026 DOI: 10.1016/j.invent.2026.100947 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Peer reviewed
Sample size 39
Population Breast cancer patients
Intervention Mindful compassion integrated with body-mind-spirit (BMS) therapy
Duration 8-week intervention; assessments at baseline and 2nd, 5th, and 8th months
Measures quality of life (QOL), anxiety, depressive symptoms, Meaning in Life Questionnaire (MLQ)
Topics Meditation Depression
Keywords Breast cancer Depressive symptoms Compassion Online intervention
Key findings Both blended and online-only mindful compassion with body-mind-spirit therapy improved depressive symptoms, meaning in life, and quality-of-life functioning in breast cancer patients. The online-only group showed greater anxiety reductions, while the blended format had a stronger impact on depression and anxiety for patients with higher initial depressive symptoms and greater breast cancer-specific distress. Increased mindfulness was linked to fewer depressive symptoms through better quality-of-life functioning.

Abstract

Objectives: To test the effectiveness of mindful compassion integrated with body-mind-spirit (BMS) therapy delivered through a blended face-to-face and online approach for breast cancer patients.

Methods: This randomized controlled trial (RCT) assigned 39 breast cancer patients to either a blended group (partial face-to-face and online sessions) or an online-only group. Both received eight weeks of therapist-guided mindful compassion with BMS group therapy. Assessments were conducted at baseline (T0) and then at 2nd (T1), 5th (T2), and 8th (T3) months, covering quality of life (QOL), anxiety, depressive symptoms, and meaning in life (MLQ).

Results: Both the blended and online-only formats improved depressive symptoms, MLQ presence, and QOL functioning. The higher anxiety reductions were in favor of the online-only group. The blended program had a stronger impact on alleviating depression and anxiety for patients with higher initial depressive symptoms and greater breast cancer-specific distress. Increased mindfulness was linked to fewer depressive symptoms through better QOL functioning.

Conclusions: Both delivery formats appear feasible and may provide psychological benefits for breast cancer patients. Future research is needed to determine the optimal balance between face-to-face and online sessions and to clarify the mechanisms underlying these effects.

Comparable studies

Other randomized controlled trials on depression, most cited first.

Study Year Design Participants
A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression Subjects with DSM-IV major depression (treatment resistant) 2006 Randomized, placebo-controlled, double-blind crossover study n = 18
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Cancer patients with life-threatening diagnoses and symptoms of depression and/or anxiety 2016 Randomized controlled trial n = 51
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Patients with cancer-related anxiety and depression 2016 Double-blind, placebo-controlled, crossover trial n = 29
Mindfulness-Based Cognitive Therapy for Depression: Replication and Exploration of Differential Relapse Prevention Effects. Recovered recurrently depressed patients 2004 Randomized controlled trial n = 73

Citations in the library

Explore topics